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A Role for the Helix-Loop-Helix Protein Id2
in the Control of Oligodendrocyte Development
ing oligodendrocytes cannot divide. The molecular basis
of this relationship is poorly understood. Interestingly,
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forever in response to their mitogens such as platelet-Department of Neurobiology
derived growth factor (PDGF). After a maximum of aboutSherman Fairchild Science Building D231
eight divisions, they stop dividing and differentiate into299 Campus Drive
oligodendrocytes. The progeny of an individual precur-Stanford, California 94305
sor cell tends to stop dividing and differentiate at around†University of Texas Southwestern Medical Center
the same time, suggesting that an intrinsic timing mech-Center for Basic Neuroscience
anism limits the number of times a precursor cell can5323 Harry Hines Boulevard
divide (Temple and Raff, 1986). When OPCs are culturedDallas, Texas 75390
in medium containing mitogens but no thyroid hormone,‡Fukui Medical University
the OPCs divide indefinitely and fail to differentiate intoDepartment of Biochemistry
oligodendrocytes (Barres et al., 1994). These studies23-3 Shimoaizuki, Matsuoka
indicated that the developmental timer consists of two910-1193 Fukui
components: a counting component that measures timeJapan
or number of cell divisions, and an effector component,
which is signaled by extrinsic hydrophobic signals in-
cluding thyroid hormone. The molecular mechanism ofSummary
this developmental timer is unknown and is of interest,
as it may provide insight into how proliferation and differ-Compared to neurons, the intracellular mechanisms
entiation are coupled.that control glial differentiation are still poorly under-
In this study, we have focused on the potential rolestood. We show here that oligodendrocyte lineage
of helix-loop-helix proteins (HLH) in controlling oligo-cells express the helix-loop-helix proteins Mash1 and
dendrocyte development. The basic HLH transcriptionId2. Although Mash1 has been found to regulate neu-
factor family regulates the development of many cellsronal development, we found that in the absence of
by regulating cell-type-specific gene expression (Wein-Mash1 oligodendrocyte differentiation occurs nor-
traub, 1993; Guillemot, 1999). Genes of the basic HLHmally. In contrast, we found that overexpression of
(bHLH) class, such as the Achaete-Scute (AS-C) com-Id2 powerfully inhibits oligodendrocyte differentiation,
plex in Drosophila and its mammalian homolog Mash1,that Id2 normally translocates out of the nucleus at
control the determination and differentiation of neuronsthe onset of differentiation, and that absence of Id2
(Johnson et al., 1990; Jan and Jan, 1993; Guillemot,induces premature oligodendrocyte differentiation in
1999). It is not yet known whether there are bHLH pro-vitro. These findings demonstrate that Id2 is a compo-
teins required for glial differentiation, but two oligoden-nent of the intracellular mechanism that times oligo-
drocyte lineage-specific bHLH proteins have been iden-dendrocyte differentiation and point to the existence
tified recently (Lu et al., 2000; Zhou et al., 2000).of an as yet unidentified MyoD-like bHLH protein nec-
Tissue-specific class B bHLH proteins control cell-essary for oligodendrocyte differentiation.
type specification and differentiation by dimerizing with
more ubiquitously expressed E2A, class A, bHLH pro-Introduction
teins such as E12 and E47. The function of tissue-spe-
cific bHLH proteins is blocked by Id (inhibitor of DNA
Compared to neurons, little is known about the intra-
binding) proteins that are structurally similar to bHLH
cellular mechanisms that control glial development. proteins except that they lack the basic DNA binding
Whereas many of the genes that control vertebrate neu- sequence (Benezra et al., 1990). Ids block differentiation
ronal development have been identified in genetic analy- in diverse cell types, including neural cells, by acting
ses of invertebrate model systems, the genes that con- as dominant-negative blockers of the function of bHLH
trol vertebrate glial development so far appear poorly proteins. Id proteins bind to class A bHLH proteins,
conserved, if at all, and thus we still know relatively little preventing their dimerization with class B bHLH proteins
about them (Granderath and Klambt, 1999). We have and activation of gene transcription (Norton, 2000). Id
been focusing on the development of oligodendrocytes proteins are ideal candidates to help couple proliferation
in the rat optic nerve. How do developing oligodendro- to differentiation, as in many cell types they are upregu-
cytes know when to divide and when to differentiate? lated by mitogens and help to promote proliferation as
As is the case for myoblasts (Gu et al., 1993), there is well as to inhibit differentiation by interacting with Rb
an obligate relationship between proliferation and differ- and other bHLH proteins responsible for differentiation.
entiation in the oligodendrocyte lineage (Temple and In the present study, we have taken advantage of
Raff, 1986; Barres and Raff, 1994). Dividing oligodendro- our ability to highly purify and culture oligodendrocyte
cyte precursor cells (OPCs) cannot myelinate; myelinat- precursor cells (OPCs) to begin to examine whether they
express HLH proteins that help to control their develop-
ment. We show that OPCs express Mash1 and Id2 mRNA§ To whom correspondence should be addressed (e-mail: barres@
stanford.edu). and protein. We show that both the ability of oligoden-
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Figure 1. Mash1 Immunoreactivity in the De-
veloping Rat Optic Nerve and in Acutely Iso-
lated Rat Optic Nerve Glial Cell Types
(A–D) Cryosections of developing rat optic
nerves were stained with mouse anti-Mash1
antibody, followed by a biotinylated anti-
mouse IgG antibody and a FITC-conjugated
Streptavidin. (E–J) Acutely isolated P4 optic
nerve cells were cultured in a serum-free me-
dium in the presence of PDGF for 2 hr. They
were double labeled with mouse anti-Mash1
antibody (H, I, and J) and a rabbit antiserum
(E, F, and G) for cell-type identification, fol-
lowed by a biotinylated anti-mouse IgG anti-
body. Signals were detected by a FITC-conju-
gated Streptavidin and a Cy3-conjugated
anti-rabbit antibody. In developing rat optic
nerve, Mash1 immunoreactivity was detected
primarily in a subset of cells at the chiasm
end (arrows) of E18 (A and B) optic nerves
but became more evenly distributed in a sub-
set of cells along the entire course of the
nerve by P8 (C) and P18 (D). In acutely iso-
lated rat optic nerve glial cells, Mash1 immu-
noreactivity was expressed by NG-2-positive
OPCs (G and J), where it was localized to
the nucleus. Mash1 immunoreactivity was not
detected in GFAP-positive astrocytes (E and
H) or by PLP-positive oligodendrocytes (F
and I). Scale bar: (A) 300 mm, (B–D) 50 mm,
(E–J) 20 mm.
drocytes to differentiate and the timing of oligodendro- A bHLH protein E47, and the class B bHLH protein
Mash1.cyte differentiation are unaffected in the absence of
Mash. In contrast, we find that Id2 overexpression Northern blots were performed on mRNA isolated
from OPCs purified from P5 rat brain to confirm theblocks oligodendrocyte differentiation and enhances
proliferation, that Id2 normally translocates out of the presence of full-length mRNAs at the expected size of
Mash1 and Id2. Using a P32-labeled cDNA probe fornucleus at the onset of differentiation, and that absence
of Id2 slows proliferation and causes premature differen- Mash1, a 2.5–2.8 kb transcript was detected, which is
the same size as full-length Mash1 mRNA (Johnson ettiation of OPCs in vitro. These findings demonstrate a
role for Id2 in controlling the timing of oligodendrocyte al., 1990). Similarly a full-length Id mRNA was detected,
although homology between Id family members pre-differentiation in vitro and point to the existence of an
as yet unidentified bHLH protein necessary for oligoden- cluded a definite identification of Id2 mRNA. To identify
the specific Id family members expressed by OPCs,drocyte development.
we performed RT–PCR analysis of OPC mRNA using
primers designed to identify specific Id family members
Results (see Experimental Procedures). mRNAs for Id1, 2, or 3
were identified; we did not examine the OPCs for Id4
PCR Analysis of Expression of HLH mRNAs mRNA (see Discussion).
by Developing Oligodendrocytes
To determine whether oligodendrocyte precursor cells
(OPCs) express helix-loop-helix proteins (bHLH), we de- Immunocytochemical Localization of Mash1
and Id Proteins in Oligodendrocyte Precursorsigned degenerate primers from known families of HLH
proteins and performed RT–PCR on mRNA extracted Cells In Vitro and In Vivo
To determine whether Mash1 protein was present infrom OPCs undergoing differentiation in the presence
of thyroid hormone (see Experimental Procedures). Au- developing glial cells in the rat optic nerve, we performed
immunostaining on optic nerve cryosections using atomatic sequence analysis of the PCR fragments identi-
fied three different HLH mRNAs: an Id protein, the class monoclonal anti-Mash1-specific antibody kindly pro-
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Figure 2. Id2 Immunoreactivity in Acutely
Isolated Rat OPCs
OPCs were purified from E18 (A and D), P8
(B and E), and P18 (C and F) optic nerves,
cultured in a serum-free medium in PDGF for
2 hr, and then double labeled by a mouse anti-
Id2 monoclonal antibody and a rabbit NG-2
antiserum, followed by a FITC-conjugated
anti-mouse IgG antibody and a Cy3-conju-
gated anti-rabbit antibody. At all three ages,
nearly all OPCs were NG-2 positive and
brightly Id2 positive. Id2 staining was local-
ized to the nucleus. Scale bar: 20 mm.
vided by David Anderson (Lo et al., 1991). In sections were Id2 positive. To confirm that OPCs express Id2,
we double labeled acutely isolated optic nerve glial cellsof embryonic day 18 (E18) optic nerve, bright nuclear
staining was present in a subset of optic nerve glial from E18, P8, and P18 rat optic nerves, using the mono-
clonal anti-Id2 antibody and a polyclonal NG2 antiserum.cells. These cells were present primarily in clusters at the
chiasm side nerve (Figures 1A and 1B). Mash1-positive Greater than 95% of NG2-positive OPCs were Id2 posi-
tive (Figure 2). These results show that embryonic andcells became more uniformly distributed along the nerve
by postnatal day 8 (P8) (Figure 1C). The intensity of postnatal OPCs express both Mash1 and Id2 proteins.
Mash1 labeling progressively decreased by P18 (Figures
1C and 1D). This pattern of staining, with a chiasm to Effect of Time of Culture and Thyroid Hormone
on Levels of Mash1 and Id2 Immunoreactivityretina gradient at E18 that disappears by P8, reflects
the previously reported distribution of OPCs, and not in Oligodendrocyte Precursor Cells
If Mash1 or Id2 regulate the timing of OPC differentiation,that of oligodendrocytes or astrocyte lineage cells.
To identify the Mash1-expressing cell type, we per- their levels might increase or decrease over time or
successive divisions in culture. We therefore investi-formed double immunostaining on acutely isolated optic
nerve cells (see Experimental Procedures). OPCs were gated whether the levels of Mash1 or Id2 immunmoreac-
tivity in OPCs changed during 7 days of culture. Welabeled using an NG2 rabbit antiserum (Levine and Nishi-
yama, 1996), astrocytes were labeled using a GFAP rab- purified OPCs from P1 optic nerves, cultured them at
clonal density, and then stained them after 1, 3, and 7bit antiserum, and oligodendrocytes were labeled using
a proteolipid protein (PLP) antiserum (see Experimental days of culture in serum-free medium containing survival
factors and mitogens but lacking thyroid hormone. AtProcedures). At P4, greater than 95% of NG-2-positive
cells were Mash1 positive (Figures 1G and 1J), a com- all three of these time points, bright Mash1 and Id2
immunoreactivity was present in nearly all of the OPCsmonly used marker for OPCs. None of the GFAP-positive
type-1 astrocytes (Figures 1E and 1H) or PLP-positive and localized to their nuclei (Figure 3). Even after 7 days
of proliferation in culture, there was no obvious changeoligodendrocytes (Figures 1F and 1I) expressed detect-
able Mash1. Thus, OPCs specifically express Mash1. in the levels of immunoreactivity of Mash1 or Id2 (Fig-
ure 3).To determine whether OPCs express Id proteins, we
first did a preliminary experiment in which we immuno- If either Mash1 or Id2 mediates the thyroid hormone–
controlled effector component of the timing mechanism,stained OPCs in culture with various Id-specific antisera
(see Experimental Procedures). We found that antibod- then their levels might be strongly regulated by thyroid
hormone. To determine whether thyroid hormone (T3)ies to Id1 and Id3 all stained OPCs diffusely, but that
Id2 staining was specifically localized to the nucleus; regulates the expression of Mash1 or Id2, we purified
P1 OPCs and cultured them for 1 day in the presencefurthermore, two different Id2 antibodies produced an
identical pattern of staining (see below). For the rest of of both survival factors and mitogens, in the presence
or absence of T3. Bright nuclear Id2 immunoreactivitythis study, we decided to focus on Id2 because of its
preferential nuclear localization. was present in 93% 6 2% of the OPCs after 1 day of
culture regardless of the presence or absence of T3We next stained cryosections with an Id2 monoclonal
antibody (see Experimental Procedures). The specificity (Figure 3). In contrast, however, 96% 6 3% of OPCs
had rapidly lost Mash1 expression after only 1 day ofof this antibody for Id2 was confirmed by Western blot-
ting (data not shown). As expected, the majority of cells culture. (Figure 3). Thus, T3 has no effect on Id2 levels
but strongly regulates Mash1 levels negatively.in cryosections prepared from developing optic nerves
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Figure 3. Mash1 and Id2 Immunoreactivity in Proliferating OPCs In Vitro
OPCs were purified from P1 rat optic nerves and cultured in a serum-free medium in the presence of PDGF for 1, 3, or 7 days without T3
(A–C, E–G, I–K, and M–O) or in the presence of both PDGF and T3 for 1 day (D, H, L, and P) prior to immunolabeling. Mash1 immunoreactivity
is shown in (A)–(D), and Id2 immunoreactivity is shown in (I)–(L). All cells were visualized using a nuclear fluorescent Hoechst counterstain
(E–H and M–P). Mash1 immunoreactivity was easily detected throughout the culture period in the absence of T3 but was lost by 24 hr after
the addition of T3, while Id2 immunoreactivity was easily detected throughout the culture period regardless of the presence or absence of
T3. Scale bar: 50 mm.
Although oligodendrocytes within the optic nerve and Effects of Oligodendrocyte Differentiation on Mash1
and Id2 Expression and Localizationimmediately after isolation did not express Mash1 immu-
noreactivity, we noticed that in culture nearly all oligo- We next investigated whether Id2 or Mash1 expression
or localization is altered when OPCs differentiate intodendrocytes, but not astrocytes or meningeal cells, ex-
pressed bright nuclear Mash1 immunoreactivity. This oligodendrocytes. We purified OPCs from P1 rat optic
nerves and cultured them in serum-free medium, lackingexpression of Mash1 in cultured oligodendrocytes was
also dependent upon thyroid hormone and was ob- thyroid hormone, but containing survival factors and
mitogens to stimulate proliferation (see Experimentalserved only in the absence of T3.
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Procedures). In some cultures, we removed the mitogen
PDGF to trigger oligodendrocyte differentiation. Four
days after removal of PDGF, nearly all of the OPCs had
differentiated into GC-positive, highly process-bearing
oligodendrocytes, as expected. The OPC cultures
(which still contained PDGF) and the oligodendrocyte
cultures (which lacked PDGF) were stained using the
Mash1 monoclonal antibody. Nearly all of the OPCs (Fig-
ure 4A) as well as the oligodendrocytes (Figure 4B) were
Mash1 positive. Both in OPCs and oligodendrocytes,
Mash1 was localized to the nucleus. Thus, despite the
continued presence of nuclear Mash1, oligodendrocyte
differentiation occurred normally.
In contrast, when we stained OPC and oligodendro-
cyte cultures prepared identically to those described
above, we found that the majority of OPCs and oligoden-
drocytes were Id2 positive (Figures 4C and 4D). How-
ever, the localization of the Id2 immunoreactivity had
dramatically changed during differentiation. Id2 was in
all cases localized to the nucleus of OPCs (Figure 4C)
but to the cytoplasm of oligodendrocytes (Figure 4D).
Id2 nuclear immunoreactivity was never detected in GC-
positive oligodendrocytes.
We next investigated whether the translocation of Id2
to the cytoplasm occurs before or after differentiation.
If Id2 plays a role in controlling differentiation, it should
translocate prior to differentiation, as it can only inhibit
differentiation by binding to bHLH proteins in the nu-
cleus where they regulate gene expression. We mea-
sured the time course of Id2 translocation by staining
the purified OPC cultures at various time points after
oligodendrocyte differentiation was triggered by re-
moval of PDGF from the culture medium. In the same
cultures, we followed the appearance of oligodendro-
cytes by staining with an anti-galactocerebroside (GC)
monoclonal antibody. As shown in Figure 4E, we found
that by 48 hr after removal of PDGF, Id2 had translocated
to the cytoplasm in 90% of the OPCs, but little oligoden-
drocyte differentiation had occurred until after another
2 days of culture. These observations show that the
translocation of Id2 out of the nucleus precedes differen-
tiation by about 2 days, which is consistent with the
possibility that Id2 plays a role in controlling the timing
or ability of OPCs to differentiate into oligodendrocytes.
Effect of Id2 Overexpression on Differentiation
of Oligodendrocyte Precursor Cells
To directly determine whether Id2 can inhibit oligoden-
Figure 4. Localization of Mash1 and Id2 in OPCs Induced to Differ-
drocyte differentiation, we investigated whether Id2 entiate by PDGF Removal
overexpression would inhibit the ability of OPCs to dif- Purified OPCs isolated from P1 rat optic nerves were cultured in a
ferentiate. We purified P8 OPCs and transfected them serum-free medium in the presence (A and C) or absence of PDGF
with either a control plasmid expression vector encoding (B and D). After 3 days, they were stained with either the mouse
anti-Mash1 antibody or the Id2 antiserum. Mash1 was expressedgreen fluorescent protein (GFP) or a rat Id2 gene to-
in the nuclei of nearly all OPCs (A) and oligodendrocytes (B). Id2gether with GFP (see Experimental Procedures). Cells
protein was found in the nuclei of nearly all OPCs (C) but translocatedoverexpressing Id2 displayed strong Id2 immunoreac-
to cytoplasm upon oligodendrocyte differentiation (D). A time course
tivity in both their cytoplasm and nucleus (data not of the percentage of cells expressing nuclear Id2 immunoreactivity
shown); presumably, the overexpression overloaded the or GC immunoreactivity after PDGF withdrawal is shown in (E).
E2A protein–mediated nuclear translocation system Translocation of Id2 from the nucleus to the cytoplasm occurred
48 hr prior to morphological and antigenically detected signs of(Deed et al., 1996). We cultured the test and control cells
oligodendrocyte differentiation. All values are shown as mean 6in medium lacking mitogens in order to allow them to
SEM (n 5 3). Scale bar: 20 mm.differentiate into oligodendrocytes. After 3 days of cul-
ture, most of the OPCs that had been transfected with
the control vector and were expressing GFP had differ-
entiated into process-bearing GC-positive oligodendro-
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negative (Figures 5B and 5D). Although Id2 overexpres-
sion blocked their ability to differentiate into postmitotic
oligodendrocytes, it did not stimulate them to divide in
the absence of mitogen based on BrdU incorporation
and on average clone size. Interestingly, however, Id2
overexpression did significantly increase the rate of pro-
liferation in response to PDGF by nearly 50% (data not
shown). Over 3 days of culture, nearly 70% of the control
OPCs differentiated into oligodendrocytes, whereas
only about 5% of OPCs overexpressing Id2 were able
to differentiate, as judged by acquisition of GC immuno-
reactivity (Figure 5E). These data demonstrate that Id2
overexpression blocks the differentiation of OPCs and
does so without stimulating their proliferation.
Effects of Mash1 and Id2 Deficiency on OPC
Proliferation and Differentiation
Our findings that Id2 is present in the nucleus of OPCs
but translocates to the cytoplasm prior to differentiation,
and that Id2 overexpression blocks OPC differentiation,
suggested that Id2 might normally control oligodendro-
cyte differentiation. To test this possibility directly, we
examined the behavior of OPCs isolated from transgenic
mice that lack Id2 (Yokota et al., 1999). Because of the
postnatal lethality of these mice, we could not assess
whether oligodendrocyte development and myelination
was altered in adult mice. However, Id2 is clearly not
necessary for the generation of oligodendrocyte lineage
cells, as many OPCs had developed by P5 based on
immunostaining of cryosections of Id22/2 brains with
specific markers (data not shown).
To more carefully analyze the effects of Id2 on oligo-
dendrocyte development, we purified OPCs from P5
wild-type and mutant mouse brains. The yields of OPCs
isolated from the Id22/2 mice tended to be slightly lower
by about 10%, approximately consistent with the slightly
decreased size of these mice. We compared the ability
of the purified OPCs to differentiate into oligodendro-
cytes in serum-free medium containing T3 in the ab-
sence of the mitogen PDGF. Over 90% of the purified
OPCs isolated from wild-type mice Id21/1 and from ho-
mozygous Id22/2 became GC-positive oligodendro-
cytes, with the typical highly process-bearing morphol-
ogy of oligodendrocytes, within 3 days of culture (Figure
6E). We next examined whether the T3-dependent ability
of oligodendrocytes to withdraw from the cell cycle and
Figure 5. Effect of Id2 Overexpression on Oligodendrocyte Precur- differentiate in the presence of mitogens was perturbed
sor Cell Differentiation in the absence of Id2. We cultured purified Id21/1 and
Purified P8 OPCs were transfected with either a control plasmid Id22/2 OPCs in the presence of both PDGF and T3 for
vector encoding GFP or an Id2-expressing vector that coexpresses 6 days, prior to measuring the percentage of cells that
GFP (see Experimental Procedures), and then cultured in serum-
had differentiated into GC-positive oligodendrocytesfree medium lacking PDGF. After 3 days, the cultures were stained
over this culture period. There was a moderate yet signif-by a mouse anti-GC monoclonal antibody, followed by a FITC-conju-
icant increase in the rate of differentiation of Id22/2 OPCsgated anti-mouse IgG antibody. The majority of OPCs expressing
exogenous Id2 (B, D, and E) failed to differentiate into oligodendro- compared to Id21/1 OPCs (Figure 6F). Similarly, in clonal
cytes, whereas most OPCs transfected by the control vector differ- studies performed in the presence of PDGF and T3, we
entiated (A, C, and E). The proportions of the stained cells were repeatedly observed premature oligodendrocyte differ-
shown as the mean 6 SEM (asterisk, p , 0.05). Scale bar: 20 mm.
entiation by Id22/2 OPCs; typically, the percentage of
oligodendrocyte clones was increased by 20% after 4–6
days of culture. In contrast, Mash1 deficiency did notcytes, as expected (Figures 5A and 5C). Remarkably,
the majority of the cells transfected with the Id2 vector, appreciably alter the rate of differentiation of purified
OPCs (Figures 6A and 6B). These results show that Id2which were easily identified by expression of GFP vec-
tors, failed to differentiate. These cells retained the typi- is not necessary for OPCs to differentiate into oligoden-
drocytes but that it normally acts to slow the rate ofcal simple bipolar morphology of OPCs and were GC
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oligodendrocyte differentiation in the presence of mito-
gens and T3.
To find out whether Id2 also regulates the rate of
proliferation, we cultured the purified Id21/1 and Id22/2
OPCs in serum-free medium containing PDGF but not
T3. After 6 days, we measured the percentage of cells
that were undergoing DNA synthesis by adding BrdU
for 4 hr and then measured the percentage of cells that
had incorporated BrdU by immunostaining. Id22/2 OPCs
had a significant decrease in BrdU incorporation com-
pared to wild-type cells (Figure 6G). In addition, when
we cultured the cells at clonal density under the same
conditions for 6 days, the average size of clones was
decreased by more than half in the absence of Id2 (Fig-
ure 6H). In contrast, Mash1 deficiency did not affect the
rate of proliferation of purified OPCs in response to
PDGF (Figures 6C and 6D).
This decrease in proliferation and clone size in the
absence of Id2 was not accounted for by a decrease in
the survival of oligodendrocyte lineage cells. After 6
days of OPC culture at clonal density in serum-free me-
dium containing PDGF and T3, dead cells accounted
for 25% 6 2% of the 1/1 cells and 28% 6 1% of the
2/2 cells. Similarly, in medium containing PDGF but no
T3, dead cells accounted for 23% 6 2% of the 1/1 cells
and 26% 6 3% of the 2/2 cells. Thus, the deficiency of
Id2 did not significantly increase cell death. In summary,
these findings show that Id2 is not necessary for OPC
survival, proliferation, or differentiation. Endogenous
levels of Id2 normally act to enhance the rate of prolifera-
tion in response to mitogens and to slow the rate of
OPC differentiation, thereby preventing premature dif-
ferentiation.
Discussion
Developing Oligodendrocytes Express
Helix-Loop-Helix Proteins
In this study, we have focused on the potential role of
helix-loop-helix proteins in oligodendrocyte develop-
ment. We found that oligodendrocyte precursor cells
express members of each of these 3 classes of HLH
proteins. OPCs expressed Mash1, Id1, Id2, Id3, and E47.
While our studies were in progress, several other labs
also reported the presence of HLH proteins in devel-
oping oligodendrocytes. Kondo and Raff (2000b, 2000c)
observed the expression of Mash1 and all four Id mRNAs
in developing OPCs. In addition, two new class B bHLH
family members, olg1/oligo2 and olg2/oligo1, were re-
cently identified and found to be specifically expressed
by oligodendrocyte lineage cells (Lu et al., 2000; Zhou
et al., 2000). These are excellent candidates to control
the generation of OPCs from multipotent neural stemFigure 6. Effects of Mash1 and Id2 Deficiency on OPC Differentia-
cells, as so far they are the earliest cell-type-specifiction and Proliferation
proteins to be expressed by developing oligodendro-OPCs were purified from brains of E20 Mash12/2 or Mash11/1 trans-
genic mice (A–D) and P5 Id22/2 or Id21/1 transgenic mice (E–H).
They were cultured in serum-free medium in the absence of PDGF
and T3 for 3 days (A and E) or for 6 days in the presence of PDGF
(B–D and F–H) with T3 (B and F) or at clonal density without T3 (C, proliferation (C and D) of OPCs with or without Mash1. However, in
D, G, and H). (A, B, E, and F) The cultures were stained with a mouse the absence of mitogens, OPCs were able to differentiate normally
anti-GC antibody, followed by a FITC-conjugated anti-mouse IgG in the absence of Id2 (E), but in the presence of mitogen they differ-
antibody. (C and G) BrdU incorporation was measured by incubating entiated significantly faster than did wild type OPCs (F). OPCs lack-
the cultures in 10 mm BrdU for 4 hr, followed by BrdU immunostain- ing Id2 also synthesized DNA at a slower rate (G) and divided signifi-
ing. There was no change in the rate of differentiation (A and B) or cantly slower (H). All values are means 6 SEM (asterisk, p , 0.05).
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cyte lineage cells. Their role in oligodendrocyte develop- by enhancing proliferation and inhibiting differentiation,
as they do for many non-neural cell types, such as mus-ment is not yet clear, however, as overexpression has
cle. For instance, neurons are generated prematurely inso far not increased the number of oligodendrocytes
transgenic mice lacking Id1 and Id3 (Lyden et al., 1999).that develop in culture or within the developing brain,
Similarly, Id proteins are expressed by developing glialand the effects of olg deficiency have not yet been exam-
cells, where Id3 helps to control astrocyte proliferationined. Whereas these recent olg studies have focused
(Tzeng and deVellis, 1997, 1998). In this study, we inves-on the mechanism by which multipotent neural stem
tigate the possible role of Id proteins in controlling oligo-cells give rise to OPCs, we have focused on the mecha-
dendrocyte differentiation. While these studies were innisms by which OPCs give rise to oligodendrocytes.
progress, Kondo and Raff (2000c) reported the identifi-
cation of all four Id mRNAs in OPCs. They showed thatMash1 Does Not Regulate Proliferation, Differentiation,
Id4 overexpression enhanced proliferation and inhibitedor the Timing of Differentiation of Oligodendrocyte
differentiation of OPCs in culture, whereas they ob-Lineage Cells
served little effect of Id1 (the effects of Id3 overexpres-Mash1 regulates the development of many types of neu-
sion have not yet been examined). They focused on Id4rons in both the peripheral and central nervous systems.
because they found that levels of Id4 mRNA and proteinMash1 is expressed by precursor cells and is downregu-
appreciably decreased in OPCs over time in culture. Inlated after differentiation. Similarly, we found that Mash1
contrast, although we identified three of these Id pro-is expressed by OPCs but not by oligodendrocytes,
teins in OPCs, we focused on Id2 because of its nuclearastrocytes, or astrocyte precursor cells and is downreg-
localization and its ability to regulate pRb, which is ex-ulated when the OPCs differentiate into oligodendro-
pressed by OPCs and has been shown to regulate thecytes within the developing rat optic nerve in vivo. While
proliferation and differentiation of developing myoblastsour studies were in progress, Kondo and Raff (2000b)
and neurons (Iavarone et al., 1994; Lasorella et al., 1996).independently showed that OPCs express Mash1 mRNA
In contrast to Mash1, we found many lines of evidenceand protein. Interestingly, they found that Mash1 levels
supporting a role for Id2 in controlling oligodendrocyteincreased in OPCs over time in culture. Despite this
differentiation. First, we found that Id2 overexpressionincrease of Mash1 in vitro over time, we found that the
nearly completely blocked the differentiation of OPCslevels of Mash1 immunoreactivity progressively de-
into oligodendrocytes. Second, we found that Id2 iscrease in OPCs within the optic nerve during develop-
normally localized to the nucleus of OPCs but translo-ment, with high levels of immunoreactivity embryonically
cates to their cytoplasm extremely early in the courseand much lower levels postnatally. This developmental
of differentiation. A nuclear localization would be consis-decrease in vivo is probably caused by the steep postna-
tent with a dominant-negative role of Id2 in antagonizingtal rise in thyroid hormone, given our finding that thyroid
differentiation, which would be relieved by cytoplasmichormone rapidly turns off Mash1 expression. Because
translocation. Third, and most importantly, we foundthyroid hormone triggers oligodendrocyte development
that OPCs that lack Id2 were capable of differentiatingand because Kondo and Raff (2000b) proposed that
normally in the absence of mitogen. However, in theMash1 may play a crucial role in the timing mechanism
presence of mitogen, compared with wild-type OPCs,that controls oligodendrocyte development, we tested
the Id22/2 OPCs proliferated significantly more slowlythe effects of Mash deficiency on oligodendrocyte de-
and differentiated prematurely in response to T3 stimu-velopment. We found that OPCs were able to differenti-
lation. These findings demonstrate that Id2 normallyate normally and that the timing of their differentiation
plays a role in the timing mechanism that regulates oligo-
in response to thyroid hormone was normal. These find-
dendrocyte development by enhancing the rate of prolif-
ings do not support a role for Mash1 in oligodendrocyte
eration and by slowing the rate of differentiation.
development. Why does Id2 translocate out of the nucleus into the
What function might Mash1 have in oligodendrocyte cytoplasm early during oligodendrocyte differentiation?
lineage cells if it does not control oligodendrocyte differ- The nuclear localization of Id proteins is regulated by
entiation? Recently, it was discovered that OPCs cul- an E protein–mediated chaperone mechanism (Deed et
tured under certain conditions have the ability to be- al., 1996). In the absence of E2A proteins, Id3 remains
come “reprogrammed” to multipotential neural stem in the cytoplasm of COS cells. Cotransfection of E47,
cells able to generate neurons as well as glial cells which has a nuclear localization signal, binds to and
(Kondo and Raff, 2000a). Our finding that T3 rapidly induces the nuclear translocation of Id3. Similarly, E47
downregulates Mash1 raises the interesting possibility has been shown to mediate the nuclear translocation
that the presence of Mash1 in OPCs might correlate of Id2 (Y. Y., unpublished data). The preferential localiza-
with, or be necessary for, their ability to undergo neuro- tion of Id2 in the nucleus of dividing OPCs is therefore
genesis. If so, the T3-mediated downregulation of most likely explained by their normal coexpression of
Mash1 might explain why multipotential neural stem E47. The movement of Id2 out of the nucleus early during
cells that persist with the adult mammalian brain appear differentiation most likely reflects the upregulation of
unable to generate many neurons in vivo although they an as yet to be identified class B bHLH protein that
can in vitro. preferentially binds to E47. Ultimately, Id2 mRNA is
downregulated by oligodendrocytes as they mature
Id2 Regulates the Timing of OPC Differentiation (Tzeng and Vellis, 1998).
into Oligodendrocytes Our observations raise the question of why so many
Id proteins are expressed by developing neuronal pre- different Id proteins are expressed by developing oligo-
dendrocytes. It is likely that these proteins have redun-cursor cells and regulate the timing of their generation
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Figure 7. A Model for How Proliferation and
Differentiation Are Coordinated in Developing
Oligodendrocytes
(A) When mitogens are present, proliferation
is stimulated by the phosphorylation of pRb,
releasing E2F from sequestration, allowing it
to transactivate cell cycle genes. In addition,
differentiation is impeded when Id2 is phos-
phorylated, moves into the nucleus, and se-
questers E47 and any unphosphorylated
pRb, preventing activation of genes needed
for differentiation by a hypothesized class B
“OligoD” bHLH protein.
(B) When mitogens are withdrawn, pRB loses
its phosphorylation allowing it to sequester
E2F, inducing cell cycle arrest. At the same
time, differentiation is promoted by Id2, which
when unphosphorylated exits the nucleus
freeing the class A bHLH protein E47 to heter-
odimerize with OligoD, which along with un-
phosphorylated pRB activates genes neces-
sary for differentiation. A similar mechanism
is thought to control myoblast differentiation.
dant functions. Both Id2 and Id4 overexpression inhibit instance, Rb is necessary for the MyoD-stimulated gene
expression underlying muscle differentiation. MyoD actsOPCs from differentiating into oligodendrocytes. Al-
though we observed premature differentiation and loss in concert with other factors besides pRb to trigger
muscle differentiation. Heterodimerization with class Aof proliferative ability in the absence of Id2, it is quite
possible that compensatory mechanisms involving the bHLH proteins such as E47 is also necessary. Thus, we
postulate that an as yet to be identified class B bHLHremaining Id proteins prevented a far more dramatic
phenotype. Id proteins might be regulated differentially; protein is upregulated during oligodendrocyte differenti-
ation and, together with interacting proteins such asfor instance, Id4 levels decrease over time in culture,
whereas Id2 levels do not appear to. In addition, Notch E47 and pRb, promotes oligodendrocyte-specific gene
expression (Figure 7). Importantly, Id2 is unique amongactivation profoundly upregulates Id1 and Id3 but not
the other two Id proteins (S. W. and B. A. B, unpublished the Id proteins in being able to bind to and disrupt the
antiproliferative effects of the tumor suppressor proteindata). Id proteins might also have different functions, as
they are differentially posttranslationally modified (Hara Rb when it is unphosphorylated (Iavarone et al., 1994;
Lasorella et al., 1996, 2000; Norton, 2000).et al., 1997), differentially bind to Rb (Iavarone et al.,
1994) and to various bHLH proteins, and have different Our findings provide insight into the molecular mecha-
nism that counts and limits the maximum number ofbiological activities (Lyden et al., 1999; Melnikova et al.,
1999). divisions an OPC can make. Id2 must directly participate
in this mechanism, as it helps to control how many
divisions developing OPCs can make before they differ-A Tentative Model for the Timing Mechanism
that Controls Oligodendrocyte Differentiation entiate. It has been previously suggested that the OPCs
might count divisions by dilution of a stable proteinOur findings suggest that Id proteins, including Id2, may
be at the heart of a control mechanism that links prolifer- (Temple and Raff, 1986). In fact, the levels of Id4 do
decrease over time, suggesting that it may play such aation to differentiation in developing oligodendrocytes.
Id upregulation would antagonize an as yet to be identi- role, although it is not known whether Id42/2 OPCs would
prematurely differentiate as occurs when Id2 is absentfied MyoD-like bHLH protein, “OligoD,” that is necessary
for oligodendrocyte differentiation (Figure 7). In the pres- (Kondo and Raff, 2000c). Although we did not observe
any obvious change in Id2 immunoreactivity, Id4 andence of mitogens, Id levels will be high and prevent
differentiation. In the absence of mitogens, Id leaves the Id2 might well collaborate, or an Id2 binding protein
might change in level over time. In addition, certain mol-nucleus and differentiation ensues. Muscle cells and
neurons are similar to oligodendrocytes in that they, too, ecules that increase over time may also participate in
the timer, such as the thyroid hormone receptors TRb1have a tightly coupled obligate relationship between
proliferation and differentiation. This coupling is thought (Gao et al., 1997) and TRb2 (Barres et al., 1994) and
the cyclin-dependent kinase inhibitor p27 (Casaccia-to be mediated by Id proteins and also by the retinoblas-
toma tumor suppressor protein, Rb. Bonnefil et al., 1997; Durand et al., 1997, 1998; Durand
and Raff, 2000).Rb, in its phosphorylated state, which is induced by
mitogenic stimulation, promotes growth by unbinding It is clear that the molecular mechanisms that limit
the number of divisions and that couple proliferation tofrom the transcription factor E2F, allowing it to activate
gene expression necessary for proliferation. Unphos- differentiation involve complex, most likely redundant,
signaling networks. The levels of many molecules, somephorylated Rb proteins are necessary for promoting dif-
ferentiation in some cell types, such as developing mus- known and many unknown, change with time in culture.
How can we figure out which of these changes is primarycle and neurons (Gu et al., 1993; Toma et al., 2000). For
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the phage library. The positive clones were sequenced and identifiedrather than secondary in controlling oligodendrocyte dif-
through sequencing.ferentiation? Gene chip analyses offer the possibility of
identifying the earliest genes to change, and the ability MYOD-5: AA(A/G)ATIAA(T/C)GA(A/G)GCITT(T/C)GA
to examine highly purified populations of wild type and MYOD-3: A(A/G)IAT(T/C)TCIAC(C/T)TTIGG
E12-5: GCIAA(T/C)AA(T/C)GCI(A/C)GIGAmutant OPCs over time promises to be a powerful future
E12-3: TTIGT(C/T)TGIG(G/C)(T/C)TT(G/A)TCapproach to understanding the molecular basis of oligo-
ASCT-5: AA(T/C)(A/C)GIGTIAA(A/G)(C/T)(A/T)IGTdendrocyte differentiation.
ASCT-3: C(G/T)IGT(A/G)TA(C/T)TCIACIGC
SPLIT-5: GCI(A/C)GIATIAA(T/C)AA(A/G)TG
Experimental Procedures SPLIT-3: TCIA(G/A)IATITCIGC(C/T)TT
Step-by-step protocols for all procedures are available upon request RT–PCR Confirmation of HLH Proteins
(barres@stanford.edu). Messenger RNA was purified cultured oligodendrocytes and OPCs,
and was reverse transcribed using Superscript II (GIBCO) with a
Reagents random hexamer (10 mM) as a primer in a 35 ml reaction containing
Recombinant human CNTF was generously provided by Regeneron. 13 Superscript II reverse transcriptase buffer, 10 mM of each dATP,
PDGF and NT-3 were obtained from Peprotech (NJ). Insulin was dTTP, dCTP, and dGTP, and 20 U of RNasin (GIBCO). For PCR
obtained from Sigma. Antibodies were kindly provided as follows: amplification, specific oligodendrocyte primer pairs (0.5 mM each)
PLP antiserum (W. Stoffel), NG-2 antiserum (J. Levine), Mash1 were incubated with 1 ml of cDNA and 1 U of Taq polymerase (Perkin
monoclonal antibody (D. Anderson). Other antibodies were commer- Elmer) in a 20 ml of reaction mixture that included 13 Taq buffer,
cially obtained: CC-1 monoclonal antibody (Oncogene Science, 100 mM each dATP, dCTP, dGTP, and dTTP. Typical cycle parame-
APC-7) and GFAP antiserum (Dako); Id2 antiserum (Santa Cruz) and ters were 1 min at 948C, 1 min at 598C, and 3 min at 728C for 20–30
Id2 monoclonal antibody (PharMingen). cycles followed by a cycle at 728C for 10 min. The whole reaction
was then fractionated on 1.2% regular agarose gel, and the PCR
product was visualized by ethidium bromide staining.Purification of OPCs and Oligodendrocytes
by Sequential Immunopanning ID1-S: AAGGTCGCCAGTAGCAGTG
Purified cell populations from rat optic nerve were obtained essen- ID1-A: TCTCCACCTTGCTCACTTTG
tially as previously described (Barres et al., 1988, 1992, 1993, 1994; ID2-S: AAAGCGTTGAGTCCGGTGA
Meyer-Franke et al., 1995; Shi et al., 1998). Briefly, neonatal optic ID2-A: GCTGCAGGATTTCCATCTT
nerves were obtained from S/D rats (Simonsen Labs, CA) and were ID3-S: GACATGAACCACTGCTACTC
incubated at 378C for 30 min in a papain solution (30 units/ml, ID3-A: ACAAGTTCCGGAGTGAGCTC
Worthington) and then purified by immunopanning as previously MASH1-S: CCCAACTGGTTCTGAGGAC
described. MASH1-A: CCCATTTGACGTAGTTGG
To purify OPCs from Mash1 knockout mice, whole brains were GAPDH-S: ATTGTCAGCAATGCATCCTGCA
obtained from E20 mice. To purify OPCs from Id2 knockout mice, GAPDH-A: AGACAACCTGGTCCTCAGTGTA
whole brains were obtained from P5 mice. Brain cell suspensions
were prepared using papain and then immunopanned. Cells were
Genotyping of Transgenic Mice
placed on the anti-Thy1.2 plate for 30 min at room temperature,
Genomic DNAs were isolated from mouse tails used Qiagen
after which the nonadherent cells were transferred to the anti-GC
DNAeasy kits. To identify the genotypes, specific oligodendrocyte
plate to deplete oligodendrocytes. The nonadherent cells were then
primer pairs (0.5 mM each) were incubated with 1 ml of cDNA and
transferred to the O4 dish to collect the OPCs.
1 U of Taq polymerase (Perkin Elmer) in a 20 ml of reaction mixture
that included 13 Taq buffer, 100 mM each dATP, dCTP, dGTP, and
Culture of Purified OPCs and Oligodendrocytes dTTP. Typical cycle parameters were 1 min at 948C, 1 min at 608C,
Approximately 5000 purified OPCs were cultured on glass cov- and 2 min at 728C for 35 cycles followed by a cycle at 728C for 10
erslips in 24-well plates (Falcon) that had been coated with PDL in min. The whole reaction was then fractionated on 1.2% regular
a serum-free medium containing DMEM (GIBCO). The serum-free agarose gel, and the PCR product was visualized by ethidium bro-
medium included bovine serum albumin (BSA), selenium, putres- mide staining. Primers for Mash1 wild type: Jim1, CCCAACTGGTTC
cine, transferrin, and progesterone, pyruvate (1 mM), glutamine (2 TGAGGAC; Jim2, CCCATTTGACGTAGTTGG. Primers for Mash1
mM), insulin (5 mg/ml), CNTF (1 ng/ml), PDGF (10 ng/ml), and NT-3 mutant: Neo1, GATCTCCTGTCATCTCACCT; Neo2, ATGGGTCACG
(1 ng/ml). For in vitro differentiation of oligodendrocytes, PDGF and ACGAGATCCT. Primers for Id2 wild type: YP-3, TCTGAGCTTATGT
NT-3 were omitted from the medium. CGAATGATAGC; YP-21, CGTGTTCTCCTGGTGAAATGGCTG. Prim-
ers for Id2 mutants: NED-1, TCGTGCTTTACGGTATCGCCGCTC;
YP-21, CGTGTTCTCCTGGTGAAATGGCTG.Construction of a Directional Lambda Phage
Oligodendrocyte Library and Isolation
of HLH Proteins Immunofluorescence Staining for Primary Cultures
and Optic Nerve SectionsMessenger RNA was extracted from highly purified differentiating
oligodendrocytes. Double-stranded cDNAs were made using After fixation with 4% paraformaldehyde for 10 min at room tempera-
ture, cells were incubated for 30 min in a 50% goat serum solutionGIBCO Superscript II cDNA Construction Kit and ligated into Not
I–Sal I phage arms. The recombinant phages were packed and deliv- containing 1% BSA and 100 mM l-lysine to block nonspecific binding
and Triton 0.4% to permeabilize the membrane. In order to stainered into proper host cells (Stratagene GigPak Gold II system).
For PCR screening, degenerate primers were made according the surface antigens of optic nerve glial cells, cells were incubated
in monoclonal A2B5 antibody, anti-GC antibody, or anti-GFAP, fol-to known bHLH sequences. mRNA extracted from differentiating
oligodendrocytes was reverse transcribed into cDNA and used as lowed by fluorescein-coupled goat anti-mouse IgG (Jackson, 10 mg/
ml), or cells were incubated with polyclonal anti-NG2, CC-1, or anti-template for polymerase chain reaction. After gel electrophoresis,
bands with proper size were cut out and subcloned into TA vector GFAP antibodies, followed by fluorescein-coupled goat anti-rabbit
IgG (Jackson, 10 mg/ml). The coverslips or slides were mounted in(Invitrogen). PCR products were then sequenced and compared
with known bHLH proteins for similarity through Blast search. The Citifluor on glass slides, sealed with nail varnish, and examined in a
Zeiss Axioskope fluorescence microscope. In order to stain Mash1,candidate clones were radiolabeled as probes to confirm their ex-
pression on Northern blot and also to obtain full-length cDNAs from cells were incubated in monoclonal anti-Mash1 antibody (a gener-
ous gift from Dr. David Anderson), followed by biotinylated goatthe oligodendrocyte library. The identity of the full-length clones
was then determined by sequencing. For oligonucleotide screening, anti-mouse IgG (Vector, 10 mg/ml). The nuclear staining was visual-
ized with fluorescein-conjugated Streptavidin (Vector, 10 mg/ml).degenerate oligo was end radiolabeled and used as probe to screen
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After perfusion with 4% paraformaldehyde, optic nerves were cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligo-
dendrocyte differentiation. EMBO J. 16, 306–317.transferred to 30% sucrose/PBS and frozen in O.C.T. compound
(Tissue-Tek). Seven-micromolar cryosections were collected on gel- Durand, B., Fero, M.L., Roberts, J.M., and Raff, M.C. (1998). p27Kip1
atin (Sigma)-coated slides. For immunostaining, slides were dried alters the response of cells to mitogen and is part of a cell-intrinsic
at 378C for 30 min and incubated for 1 hr in a 50% goat serum timer that arrests the cell cycle and initiates differentiation. Curr.
solution containing 1% BSA and 100 mM l-lysine to block nonspe- Biol. 8, 431–440.
cific binding and Triton 0.4% to permeabilize the membrane. Sec-
Gao, F.B., Durand, B., and Raff, M. (1997). Oligodendrocyte precur-
tions were double stained with polyclonal antibodies against differ-
sor cells count time but not cell divisions before differentiation. Curr.
ent glial cell markers and monoclonal anti-Mash1 antibody, followed
Biol. 7, 152–155.
by fluorescein-coupled goat anti-rabbit IgG (Jackson, 10 mg/ml)
Granderath, S., and Klambt, C. (1999). Glial development in theand biotinylated anti-mouse IgG, and later by fluorescein-coupled
embryonic CNS of Drosophila. Curr. Opin. Neurobiol. 9, 531–536.Streptavidin (Vector, 10 mg/ml). The slides were mounted in Citifluor,
sealed with nail varnish, and examined with a Zeiss Axioskope fluo- Gu, W., Schneider, J.W., Condorelli, G., Kaushal, S., Mahdavi, V.,
rescence microscope. and Nadal-Ginard, B. (1993). Interaction of myogenic factors and
All data in the text and figures are shown as means 6 SEM (n 5 the retinoblastoma protein mediates muscle cell commitment and
3, coverslips per condition) and were repeated in three separate differentiation. Cell 72, 309–324.
experiments. Guillemot, F. (1999). Vertebrate bHLH genes and the determination
of neuronal fates. Exp. Cell Res. 253, 357–364.
Transfection of OPCs with Id2 Hara, E., Hall, M., and Peters, G. (1997). Cdk2 dependent phosphory-
The Id2 gene was inserted into a mammalian expression vector lation of Id2 modulates activity of E2A-related transcription factors.
pIRES EGFP (Clontech) to create a plasmid overexpressing Id2, EMBO J. 16, 332–342.
pIRES Id2-EGFP. Purified OPCs were grown in PDL-coated 60 mm
Iavarone, A., Garg, P., Lasorella, A., Hsu, J., and Israel, M.A. (1994).culture dishes in the presence of mitogens until reaching 40% con-
The helix-loop-helix protein Id-2 enhances cell proliferation andfluence. Defined Sato culture medium (100 ml) was mixed with Fu-
binds to the retinoblastoma protein. Genes Dev. 8, 1270–1284.gene-6 (6 ml; Boehringer Mannheim) and with (4 mg) pIRES EGFP
Jan, Y.N., and Jan, L.Y. (1993). HLH proteins, fly neurogenesis, andand pIRES Id2-EGFP and incubated at room temperature for 15 min.
vertebrate myogenesis. Cell 75, 827–830.Thirty microliters of the transfection solution was added to each well.
Twenty-four hours after the start of the transfection, the medium was Johnson, J.E., Birren, S.J., and Anderson, D.J. (1990). Two rat homo-
removed and replaced with serum-free medium minus mitogens. logues of Drosophila achaete-scute specifically expressed in neu-
The differentiation of the oligodendrocytes was determined by im- ronal precursors. Nature 346, 858–861.
munostaining with an anti-GC antibody after 4 days. Kondo, T., and Raff, M. (2000a). Oligodendrocyte precursor cells
reprogrammed to become multipotential CNS stem cells. Science
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